Testing effectiveness (Phase 2)WithdrawnNCT06233903
What this trial is testing
18F-mFBG Expression in Neural Crest Tumors and Organs Innervated by the Sympathetic Nervous System
Who this might be right for
NeuroblastomaPheochromocytomaParaganglioma
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)